Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: a case report
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Vázquez Bourgon, Javier
; Rodríguez-Rodríguez, Pablo; Gómez Ruiz, Elsa; Artal Simón, Jesús Ángel
; Crespo Facorro, Benedicto
Fecha
2014-11Derechos
Alojado según Resolución CNEAI 10/12/25 (ANECA)
Publicado en
Annals of Clinical Psychiatry, 2014, 26(4), 301-302
Editorial
Taylor & Francis
Resumen/Abstract
Obsessive-compulsive symptoms (OCS) are common among patients with schizophrenia, with prevalence rates up to 30.3%.1 Although the pathophysiology underlying the presence of OCS in schizophrenia is unknown, it has been suggested their appearance may be a complication of secondgeneration antipsychotics, mainly because of these drugs' combined antagonistic action on D2 and 5-HT2 receptors. We report on a patient with psychosis who developed OCS when treated with paliperidone longacting depot injection.
Colecciones a las que pertenece
- D22 Artículos [1290]






